SEATTLE, Aug. 20, 2015 /PRNewswire/ -- Navigating Cancer, the leading web-based patient care and engagement solution for cancer programs, announced today the close of a $10 million funding round led by Merck Global Health Innovation Fund in syndicate with ORIX Healthcare Capital, along with existing investor Rustic Canyon Partners.
Currently, Navigating Cancer partners with cancer programs nationwide and provides over a million cancer patients with a multi-faceted patient engagement portal. Now, with an enduring focus on the patient experience, the company is gearing up for the expansion of its comprehensive care and engagement platform.
By providing all of the patient centered care software that cancer programs need and cancer patients want in one platform, Navigating Cancer supports the evolution toward value-based medicine while enabling each cancer patient to be more informed and actively engaged in their care.
"Oncology is moving quickly to value-based medicine, and the need for a comprehensive patient solution for cancer programs is increasingly becoming a core need," said Gena Cook, CEO and Co-Founder. "With this funding, we will accelerate our pace in delivering the most comprehensive solution in the marketplace."
About Navigating Cancer: Navigating Cancer is the patient care and engagement company. For patients, Navigating Cancer provides a single, comprehensive hub that operates with any electronic health record vendor. This allows patients to stay informed and engaged seamlessly in their own care across multiple clinics, caregivers and geographies. For providers, Navigating Cancer offers an agile means of satisfying current requirements for Meaningful Use, Commission on Cancer and new payment reform models.
SOURCE Navigating Cancer